GoodRx Care vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Visit Oak Longevity - our pick of these two →or find your match

Oak Longevity beats GoodRx Care overall, scoring 7.5/10 vs 6.2/10. Published pricing is not a like-for-like monthly comparison: GoodRx Care is $119/mo subscription + medication; Oak Longevity is from $119/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side look at GoodRx Care and Oak Longevity to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

GoodRx Care

#44 of 54

6.2/10

GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.

Visit GoodRx Care

Higher Rated

Oak Longevity

#21 of 54

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	GoodRx Care	Oak Longevity
Why each one	The only GLP-1 prescribing service integrated with the largest prescription discount platform in the US, automatically finding the cheapest pharmacy price for your medication.	The no-subscription billing model, patients are not auto-charged each month and renew manually. Combined with the broadest medication mix (compounded GLP-1s + oral Wegovy + brand-name + longevity peptides), Oak occupies a unique position as a 'menu' platform vs. the typical single-product flow.
Our Score	6.2/10	7.5/10
Headline Price	$119/mo subscription + medication	from $119/mo
Medication Type	Brand	Both
Insurance Accepted	Yes	No
Best For	Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing, $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Watch out for	Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms	Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
Ranking	#44	#21
Get started	Visit GoodRx Care	Visit Oak Longevity

Pros & Cons Compared

GoodRx Care

Pros

+2026 subscription rewrite, $119/mo standard membership with medication priced among the lowest on the market
+Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
+Oral Wegovy pill available at $149-199/mo, one of the cheapest oral semaglutide routes
+Insurance accepted, GoodRx's integration with savings cards can stack with coverage

Cons

−Model changed from pay-per-visit to subscription, users expecting à-la-carte pricing should double-check current terms
−Compounded GLP-1s are de-emphasized on current marketing, may no longer be available
−Subscription model means ongoing monthly fee even in maintenance months
−Follow-up clinical care is still basic compared to dedicated GLP-1 platforms

Oak Longevity

Pros

+$119/mo for compounded semaglutide is among the lowest published entries in our provider table
+No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Compounded tirzepatide at $185/mo is competitively priced for a GLP-1+GIP dual agonist
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
−No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
−The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
−The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our Verdict

Oak Longevity edges out GoodRx Care with a score of 7.5/10 vs 6.2/10. Published pricing is not a like-for-like monthly comparison: GoodRx Care is $119/mo subscription + medication; Oak Longevity is from $119/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing, $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).